Genoptix, Inc.
News and overview for Genoptix, Inc.
Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 [Press Release]
PRNewswire | 18 days 5 hours 3 minutes ago
...PRNewswire-FirstCall/ -- Genoptix, Inc. , a specialized laboratory services...occurrence of unanticipated events. GENOPTIX, INC. CONDENSED CONSOLIDATED STATEMENTS... GENOPTIX, INC. CONDENSED CONSOLIDATED BALANCE...
Genoptix Announces Participation at Lazard Capital Management 6th Annual Healthcare Conference [Press Release]
PRNewswire | 13 days 10 hours 21 minutes ago
...PRNewswire-FirstCall/ -- Genoptix, Inc. , a specialized laboratory services...Director, Investor Relations of Genoptix, Inc.,+1-760-930-7150, investorrelations@genoptix.com; or Sarah Thailing,Principal...
Genoptix Ranked 15th Fastest-Growing Company in North America on Deloitte's 2009 Technology Fast 500(TM) [Press Release]
PRNewswire | 34 days 15 hours 13 minutes ago
...PRNewswire-FirstCall/ -- Genoptix, Inc. , a specialized laboratory services...Director, Investor Relations, Genoptix, Inc.,+1-760-930-7150, investorrelations@genoptix.com; or Joleen Schultz,Principal...
Genoptix Announces Participation at Investor Conferences in September [Press Release]
PRNewswire | 70 days 20 hours 41 minutes ago
...PRNewswire-FirstCall/ -- Genoptix, Inc. , a specialized laboratory services...Director, Investor Relations of Genoptix, Inc.,+1-760-930-7150, investorrelations@genoptix.com; or Joleen Schultz,Principal...
Genoptix Announces Participation at the 2009 Southern California Investor Conference [Press Release]
PRNewswire | 102 days 21 hours 11 minutes ago
...PRNewswire-FirstCall/ -- Genoptix, Inc. , a specialized laboratory services...Director, Investor Relations of Genoptix, Inc.,+1-760-930-7150, investorrelations@genoptix.com; or Joleen Schultz,Principal...
UPDATE 1-Genoptix Q3 profit beats Street; raises 2009 EPS view
Reuters | 18 days 8 hours 43 minutes ago
Nov 5 (Reuters) - Laboratory services provider Genoptix Inc (GXDX.O) posted better-than-expected quarterly earnings, helped by new customers, and raised its 2009 profit view.
Analyst Upgrades for November 6th
Investor's Business Daily | 17 days 16 hours 37 minutes ago
Nov 06, 2009 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- Analyst Upgrades for 11/6/2009... Air Methods (AIRM) upgraded to Overweight from Equal Weight at Stephens... Amazon (AMZN) upgraded to Outperform, $160 target, at Bernstein... ANSYS (ANSS) upgraded to Buy at Jefferies... Arena Resources (ARD) upgraded to Buy from Neutral, $48 target, at Global Hunter... Blue Nile (NILE) upgraded to Hold, $50 target, at Deutsche Bank... Canadian Natural Resources (CNQ) upgraded to Overweight at Barc...
7 Results
Sign up for SNM SmartBrief
Company Overview
| Company: | Genoptix, Inc. |
|---|---|
| Industry: | Medical Laboratories & Research |
| Website: | http://www.genoptix.com |
Genoptix is promoting optimal cancer diagnostics. The biotechnology company is a specialized laboratory service provider founded in 1999. It analyzes blood and tissue samples in order to diagnose and monitor diseases such as leukemia, and markets those services to community-based hematologists and oncologists treating malignancies of the blood and bone marrow, as well as other types of cancer. Its key service offerings are COMPASS (short for Comprehensive Assessment) and CHART (a condition monitoring service). Genoptix was started by Dr. Tina Nova, who also co-founded San Diego-based life science companies Ligand Pharmaceuticals and Nanogen.
Key Numbers
| Sales in U.S. Dollars (mil.) | 116.2 (2008) |
|---|---|
| One-year % Growth in Sales | 95.8 (2008) |
| Net Income in U.S. Dollars (mil.) | 31.4 (2008) |
| One-year % Growth in Net Income | 845.3 (2008) |
| Number of Employees | 307 (2008) |
| One-year % Growth in Number of Employees | 98.1 (2008) |
| Fiscal Year-End | December |